+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antitumor Antibiotic"

Gynecological Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Gynecological Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Anti-Neoplastic Agents Global Market Report 2024 - Product Thumbnail Image

Anti-Neoplastic Agents Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Blood Cancer Therapeutics: Global Markets to 2023 - Product Thumbnail Image

Blood Cancer Therapeutics: Global Markets to 2023

  • Report
  • December 2018
  • 174 Pages
  • Global
From
From
From
  • 11 Results (Page 1 of 1)
Loading Indicator

The Antitumor Antibiotic market is a subset of the Oncology Drugs market, which focuses on the development and sale of drugs used to treat cancer. Antitumor antibiotics are a type of chemotherapy drug that works by killing cancer cells or stopping them from growing and dividing. These drugs are typically administered intravenously or orally, and can be used alone or in combination with other treatments. They are used to treat a variety of cancers, including breast, lung, and colorectal cancer. The Antitumor Antibiotic market is highly competitive, with many companies vying for market share. Some of the major players in the market include Pfizer, Merck, Bristol-Myers Squibb, AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to improve the efficacy of their products and gain a competitive edge. Show Less Read more